Recently we developed a CCR10 antagonist, POL7085, using Protein Epitope Mimetic (PEM) technology, which was shown to significantly decrease allergen‐induced eosinophilic airway inflammation in an OVA‐induced allergic airway inflammation mouse model of asthma 12. The gene discussed is CCR10; the disease is asthma.